PRAX News and Press, Praxis Precision Medicines Inc. From 01/06/26

2026-01-06 16:09:50 ET More on Praxis Precision Medicines Praxis: Priced For Perfection Heading Into 2026 Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 Praxis: Moving To Strong Buy Based On Ulixacaltamide Success In Treating ET ...

BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalan...

2026-01-02 06:52:42 ET The State Street® SPDR® S&P® Biotech ETF ( XBI ) is up approximately 65% from its April 9th lows following the aftermath of the sharp but short decline in the overall markets following the announcement of ' reciprocal tariffs ' by the ad...

2025-12-31 08:15:40 ET Introduction Stock of Praxis Precision Medicines ( PRAX ) has continued north following Phase 3 data for its essential tremor, or ET, drug candidate, ulixacaltamide.... Read the full article on Seeking Alpha For further details see: Praxis:...

2025-12-30 10:15:03 ET Citigroup analyst issues CONVICTION BUY recommendation for PRAX on December 30, 2025 01:22PM ET. The previous analyst recommendation was Conviction Buy. PRAX was trading at $294.29 at issue of the analyst recommendation. The overall analyst consens...

A look at the top 10 most actives in the United States Republic Power Group Ltd (RPGL) rose 159.6% to $0.6834 on volume of 526,371,087 shares Mereo BioPharma Group plc (MREO) fell 87.6% to $0.2854 on volume of 241,447,142 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.0% t...

2025-12-29 19:39:47 ET Shares of Praxis Precision Medicines (NASDAQ: PRAX) leaped on Monday after the clinical-stage biopharmaceutical company received a Breakthrough Therapy Designation (BTD) for its experimental tremor treatment. By the close of trading, Praxis' stock pric...

A look at the top 10 most actives in the United States Republic Power Group Ltd (RPGL) rose 161.4% to $0.6882 on volume of 501,922,381 shares Mereo BioPharma Group plc (MREO) fell 87.6% to $0.2855 on volume of 215,784,569 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.2% t...

2025-12-29 09:29:05 ET More on Praxis Precision Medicines Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026 Praxis: Moving To Strong Buy Based On Ulixacaltamide Success In Treating ET Praxis Precision Medicines, Inc. (PRAX) Discusses ...

The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential tremor Praxis remains on track to submit ulixacaltamide NDA in early 2026 based on recently completed pre-NDA meeting with the FDA BOSTON, Dec. 29, 2025 (...